Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients. [electronic resource]
Producer: 20190814Description: 315-326 p. digitalISSN:- 1523-6838
- Adult
- Black or African American -- genetics
- Area Under Curve
- Cross-Over Studies
- Cytochrome P-450 CYP3A -- drug effects
- Delayed-Action Preparations -- therapeutic use
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Graft Rejection
- Graft Survival
- Humans
- Immunosuppressive Agents -- pharmacokinetics
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Molecular Targeted Therapy -- methods
- Pharmacogenetics
- Postoperative Care -- methods
- Prognosis
- Prospective Studies
- Risk Assessment
- Tacrolimus -- pharmacokinetics
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.